Fig. 1From: TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapyOverall survival associated with 1st line treatment in 107 PCNSL patients. Kaplan-Meier plot of 107 PCNSL patients, who were treated with combination chemotherapy +/− rituximab, whole brain radiation therapy (WBRT), high-dose (HD) methotrexate, and no therapy, P < 0.0001Back to article page